Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. Financials
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 8 05213 61526 84347 510--
Entreprise Value (EV)1 8 17813 72327 37048 06647 81347 242
P/E ratio 38,7x58,1x75,1x81,0x70,7x62,9x
Yield 0,65%0,46%0,23%0,27%0,34%0,38%
Capitalization / Revenue 6,64x9,45x14,1x16,6x14,5x12,9x
EV / Revenue 6,75x9,53x14,3x16,8x14,6x12,8x
EV / EBITDA 23,9x32,6x45,3x46,4x41,3x36,4x
Price to Book 7,77x11,7x18,4x24,2x18,8x15,1x
Nbr of stocks (in thousands) 92 18092 18092 18092 180--
Reference price (EUR) 87,4148291515515515
Announcement Date 01/29/201901/28/202002/18/2021---
1 EUR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 1 2121 4411 9102 8683 2713 679
EBITDA1 3424226051 0371 1571 297
Operating profit (EBIT)1 3003324728779711 069
Operating Margin 24,8%23,0%24,7%30,6%29,7%29,0%
Pre-Tax Profit (EBT)1 2853184838449431 083
Net income1 208235358594678762
Net margin 17,2%16,3%18,7%20,7%20,7%20,7%
EPS2 2,262,543,886,377,298,19
Dividend per Share2 0,570,680,681,391,751,98
Announcement Date 01/29/201901/28/202002/18/2021---
1 EUR in Million
2 EUR
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 S1 2021 Q3 2021 Q4
Net sales1 5316556971 352735748
EBITDA1 170232256487259263
Operating profit (EBIT)1 120199222-218230
Operating Margin 22,5%30,4%31,9%-29,7%30,7%
Pre-Tax Profit (EBT)1 144-203-220221
Net income1 114-144-142159
Net margin 21,5%-20,7%-19,3%21,3%
EPS2 1,24-1,56-1,531,72
Dividend per Share ------
Announcement Date 02/18/202104/21/202107/21/202107/21/2021--
1 EUR in Million
2 EUR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 126108527557303-
Net Cash position1 -----267
Leverage (Debt / EBITDA) 0,37x0,26x0,87x0,54x0,26x-0,21x
Free Cash Flow1 50,7174258219406540
ROE (Net Profit / Equities) 21,8%21,4%27,3%33,4%28,0%26,5%
Shareholders' equity1 9541 0981 3091 7772 4212 874
ROA (Net Profit / Asset) 14,0%13,8%15,6%19,6%17,8%18,7%
Assets1 1 4881 6962 2913 0273 8114 072
Book Value Per Share2 11,212,615,821,327,434,2
Cash Flow per Share2 2,473,364,526,057,449,43
Capex1 177136159342345370
Capex / Sales 14,6%9,44%8,33%11,9%10,6%10,1%
Announcement Date 01/29/201901/28/202002/18/2021---
1 EUR in Million
2 EUR
Key data
Capitalization (EUR) 47 509 669 926
Capitalization (USD) 53 762 215 600
Net sales (EUR) 1 910 100 000
Net sales (USD) 2 155 547 850
Number of employees 9 619
Sales / Employee (EUR) 198 576
Sales / Employee (USD) 224 093
Free-Float 26,2%
Free-Float capitalization (EUR) 12 439 508 341
Free-Float capitalization (USD) 14 076 619 147
Avg. Exchange 20 sessions (EUR) 21 920 082
Avg. Exchange 20 sessions (USD) 24 736 812
Average Daily Capital Traded 0,05%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA